Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 3 Renal Insufficiency, Chronic 2 Prostatic Neoplasms 2 Uterine Prolapse 1 Urologic Neoplasms 1 Urinary Tract Infections 1 Staphylococcal Infections 1 Spasm 1 Sleep Initiation and Maintenance Disorders 1 Skin Sympathetic Nerve Activity During General Anesthesia in Patients Undergoing Breast Cancer Surgery 1 Sepsis 1 Seizures 1 Schizophrenia, Treatment-Resistant 1 Schizophrenia 1 Retinitis 1 Pulmonary Arterial Hypertension 1 Pneumonia 1 Pain 1 Neutropenia 1 Neuromuscular Blockade 1 Muscle Hypotonia 1 Migraine Disorders 1 Menorrhagia 1 Meningitis, Bacterial 1 Meningitis 1 Melanoma 1 Lung Neoplasms 1 Leiomyoma 1 Intraabdominal Infections 1 Intestinal Obstruction 1

Interventions

Cisplatin 161 Fluorouracil 135 Paclitaxel 127 Radiotherapy 125 Oxaliplatin 88 Carboplatin 72 Docetaxel 71 Irinotecan 60 pembrolizumab 57 Leucovorin 57 Capecitabine 57 Radiation 48 Esophagectomy 44 Surgical Procedures, Operative 42 Drug Therapy 38 Neoadjuvant Therapy 28 Cetuximab 25 Nivolumab 24 Bevacizumab 21 camrelizumab 20 Trastuzumab 20 S 1 (combination) 19 Chemoradiotherapy 19 Magnetic Resonance Spectroscopy 18 Epirubicin 16 Albumin-Bound Paclitaxel 16 Blood Specimen Collection 15 tislelizumab 14 Taxes 14 Radiotherapy, Intensity-Modulated 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Esophageal Neoplasms × Rocuronium × Clear all

NCT02320734 2016-09-19

DEPTH

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 4 Completed

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡